MedPath

Analysis for regression of atherosclerosis in acute coronary syndrome patients after PCSK9 inhibitor therapy by using near-infrared spectroscopy and intravascular ultrasound

Not Applicable
Conditions
coronary disease
Registration Number
JPRN-UMIN000027238
Lead Sponsor
Kyoto Prefectural University of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

Patients with intolerance to PCSK9 inhibitor, intolerance to anti-coagulant and anti-platelet therapy, not crossing the NIRS-IVUS, severe complication (severe liver dysfunction, severe renal failure, uncontrolled hypertension), and unstable hemodynamics

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath